Performance of risk indices for identifying low bone density in postmenopausal women

被引:114
作者
Geusens, P
Hochberg, MC
van der Voort, DJM
Pols, H
van der Klift, M
Siris, E
Melton, ME
Turpin, J
Byrnes, C
Ross, PD
机构
[1] Merck Res Labs, Rahway, NJ 07065 USA
[2] Univ Limburg, Biomed Res Inst, Diepenbeek, Belgium
[3] Univ Maastricht, Dept Rheumatol, Maastricht, Netherlands
[4] Univ Maryland, Div Rheumatol, Baltimore, MD 21201 USA
[5] Erasmus Univ, Sch Med, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands
[6] Erasmus Univ, Sch Med, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands
[7] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
[8] Toni Stabile Ctr Prevent & Treatment Osteoporosis, New York, NY USA
关键词
D O I
10.4065/77.7.629
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To examine the ability of 4 published osteoporosis risk indices to identify women with low bone density. Subjects and Methods: Subjects included postmenopausal women 45 years and older consecutively recruited from US clinics, women from general practice centers in the Netherlands (age range, 50-80 years), women in the Rotterdam Study (the Netherlands) 55 years and older, and women aged 55 to 81 years old, screened for a clinical trial of alendronate. Bone mineral density (BMD) was measured at the femoral neck or lumbar spine; T scores represent the number of SDs below the mean for young healthy women. One risk index was calculated from age and weight; the other risk indices included up to 4 additional variables obtained by questionnaire. We calculated the sensitivity and specificity for identifying women with BMD T scores of -2.5 or less or -2.0 or less in the US clinic sample and created 3 risk categories, using each of the 4 indices. Results: Data were available for 1102 women from the US clinic sample, 3374 women in the Rotterdam Study, 23,833 women screened for a clinical trial of alendronate, and 4204 women from general practice centers in the Netherlands. Specificity for identifying BMD T scores of -2.5 or less ranged from 37% to 58% (depending on risk index) when sensitivity was approximately 90%. The prevalence of osteoporosis (defined, as T scores less than or equal to-2.5) differed widely. across the 3 risk categories, ranging from 2% to 4% for the low-risk category to 47% to 61% for the high-risk category in the US clinic sample. For spine BMD in the US clinic sample, the prevalence of T scores of -2.5 or less ranged from 7% (low risk) to 38% (high risk). The large differences in prevalence across risk categories were consistent across the other 3 samples of postmenopausal women in the United States and the Netherlands for all 4 risk indices. Conclusions: We recommend measuring BMD in women who are classified as having an increased risk of osteoporosis by using any of these risk indices because all 4 indices appear to predict low bone mass equally well. The Osteoporosis Self-assessment Tool index is easiest to calculate and therefore may be most useful in clinical practice.
引用
收藏
页码:629 / 637
页数:9
相关论文
共 34 条
[1]  
[Anonymous], 2000, FRAG IS HER FUT
[2]   FACTORS ASSOCIATED WITH APPENDICULAR BONE MASS IN OLDER WOMEN [J].
BAUER, DC ;
BROWNER, WS ;
CAULEY, JA ;
ORWOLL, ES ;
SCOTT, JC ;
BLACK, DM ;
TAO, JL ;
CUMMINGS, SR .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (09) :657-665
[3]  
BINSTOCK M, 2000, OBSTET GYNECOL S, V95, pS50
[4]   Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[5]  
Black DM, 1998, BONE, V23, pS605
[6]  
BLACK DM, 1993, OSTEOPOROSIS INT, V3, P29
[7]   Risk factors for increased bone loss in an elderly population - The Rotterdam Study [J].
Burger, H ;
de Laet, CEDH ;
van Daele, PLA ;
Weel, AEAM ;
Witteman, JCM ;
Hofman, A ;
Pols, HAP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 147 (09) :871-879
[8]   Validation of the Simple Calculated Osteoporosis Risk Estimation (SCORE) for patient selection for bone densitometry [J].
Cadarette, SM ;
Jaglal, SB ;
Murray, TM .
OSTEOPOROSIS INTERNATIONAL, 1999, 10 (01) :85-90
[9]  
Cadarette SM, 2000, CAN MED ASSOC J, V162, P1289
[10]   Evaluation of decision rules for referring women for bone densitometry by dual-energy X-ray absorptiometry [J].
Cadarette, SM ;
Jaglal, SB ;
Murray, TM ;
McIsaac, WJ ;
Joseph, L ;
Brown, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :57-63